A record of what Rupak De said publicly, with the source. Not advice.
“Bullish on Aster DM Healthcare, recommending a buy at 808 with a target of 868 and a stop loss at 769. The stock is trading within a rising channel, holding above the 50-day EMA, and the RSI has entered a bullish crossover, indicating a sustained uptrend.”
Rupak De’s track record (trackable calls only): 137 graded calls · 95% CI 34–50%
How this call is judged
A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.
Entry: ₹808, as stated.
Target ₹868, stop ₹769, as stated.
No time frame is stated, so it is tracked until a close reaches ₹868 or ₹769: there is no fixed window.
The target ₹868 was reached on a close before the stop ₹769. Hit.
The grader’s working: R3 TRADE_SETUP: entered ₹808 on 2026-07-13 (stated entry ₹808, LEVEL_CMP entry, filled); target ₹868 reached at close ₹869.7 on 2026-08-07. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.
How it played out
How this is worked out- Target or stop first
- The target was reached on a close before the stop was.
- Time to target
- The target was reached on a close 19 trading sessions (25 calendar days) after the entry.
- Worst close against it
- The closing price went as far as 2.93% against the call before the target was reached, measured from the entry price. Closing prices only; an intraday dip is never counted.
From the entry the grade used, on closing prices. This is a record of one past call and is not advice.